Giovanni Targher

833 total papers · 67.2k total citations
562 papers, 44.3k citations indexed

About

Giovanni Targher is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Giovanni Targher has authored 562 papers receiving a total of 44.3k indexed citations (citations by other indexed papers that have themselves been cited), including 353 papers in Epidemiology, 230 papers in Endocrinology, Diabetes and Metabolism and 123 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Giovanni Targher's work include Liver Disease Diagnosis and Treatment (327 papers), Diet, Metabolism, and Disease (131 papers) and Liver Disease and Transplantation (85 papers). Giovanni Targher is often cited by papers focused on Liver Disease Diagnosis and Treatment (327 papers), Diet, Metabolism, and Disease (131 papers) and Liver Disease and Transplantation (85 papers). Giovanni Targher collaborates with scholars based in Italy, United Kingdom and China. Giovanni Targher's co-authors include Christopher D. Byrne, Enzo Bonora, Giacomo Zoppini, Alessandro Mantovani, Giuseppe Lippi, Christopher P. Day, Amedeo Lonardo, Herbert Tilg, Michele Muggeo and Quentin M. Anstee and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Giovanni Targher

544 papers receiving 43.3k citations

Hit Papers

NAFLD: A multisystem disease 1998 2026 2007 2016 2015 2000 2010 2013 2016 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. NAFLD: A multisystem disease
    2015 2.2k citations Christopher D. Byrne, Giovanni Targher Journal of Hepatology profile →
  2. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.
    2000 2.1k citations Enzo Bonora, Giovanni Targher et al. Diabetes Care profile →
  3. Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
    2010 1.5k citations Giovanni Targher, Christopher P. Day et al. New England Journal of Medicine profile →
  4. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
    2013 1.4k citations Quentin M. Anstee, Giovanni Targher et al. Nature Reviews Gastroenterology & Hepatology profile →
  5. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
    2016 994 citations Giovanni Targher, Christopher D. Byrne et al. Journal of Hepatology profile →
  6. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
    2017 832 citations Leon A. Adams, Quentin M. Anstee et al. Gut profile →
  7. Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients
    2007 781 citations Giovanni Targher, Lorenzo Bertolini et al. Diabetes Care profile →
  8. Relation Between Red Blood Cell Distribution Width and Inflammatory Biomarkers in a Large Cohort of Unselected Outpatients
    2009 716 citations Giuseppe Lippi, Giovanni Targher et al. Archives of Pathology & Laboratory Medicine profile →
  9. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients.
    2009 702 citations Giuseppe Lippi, Giovanni Targher et al. Archives of Pathology & Laboratory Medicine profile →
  10. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
    1998 685 citations Enzo Bonora, Stefan Kiechl et al. Diabetes profile →
  11. The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments
    2021 542 citations Giovanni Targher, Kathleen E. Corey et al. Nature Reviews Gastroenterology & Hepatology profile →
  12. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysis
    2015 537 citations Stefano Ballestri, Stefano Zona et al. Journal of Gastroenterology and Hepatology profile →
  13. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
    2020 532 citations Giovanni Targher, Christopher D. Byrne et al. Gut profile →
  14. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
    2017 522 citations Amedeo Lonardo, Fabio Nascimbeni et al. Journal of Hepatology profile →
  15. Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
    2018 442 citations Alessandro Mantovani, Christopher D. Byrne et al. Diabetes Care profile →
  16. Complications, morbidity and mortality of nonalcoholic fatty liver disease
    2020 401 citations Alessandro Mantovani, Eleonora Scorletti et al. Metabolism profile →
  17. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
    2021 376 citations Alessandro Mantovani, Alessandro Csermely et al. ˜The œLancet. Gastroenterology & hepatology profile →
  18. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
    2015 352 citations Amedeo Lonardo, Stefano Ballestri et al. Digestive and Liver Disease profile →
  19. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
    2021 338 citations Giovanni Targher, Herbert Tilg et al. ˜The œLancet. Gastroenterology & hepatology profile →
  20. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
    2024 322 citations Giovanni Targher, Christopher D. Byrne et al. Gut profile →
  21. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
    2020 320 citations Alessandro Mantovani, Graziana Petracca et al. Gut profile →
  22. NAFLD as a driver of chronic kidney disease
    2020 313 citations Christopher D. Byrne, Giovanni Targher Journal of Hepatology profile →
  23. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus
    2017 293 citations Giovanni Targher, Amedeo Lonardo et al. Nature Reviews Endocrinology profile →
  24. Current status and future trends of the global burden of MASLD
    2024 270 citations Lei Miao, Giovanni Targher et al. Trends in Endocrinology and Metabolism profile →
  25. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis
    2020 251 citations Alessandro Mantovani, Graziana Petracca et al. Gut profile →
  26. Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies
    2021 234 citations Alessandro Mantovani, Graziana Petracca et al. Gut profile →
  27. MAFLD and risk of CKD
    2020 206 citations Dan‐Qin Sun, Yan Jin et al. Metabolism profile →
  28. Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
    2021 200 citations Alessandro Mantovani, Graziana Petracca et al. Metabolites profile →
  29. The first MASH drug therapy on the horizon: Current perspectives of resmetirom
    2024 77 citations Salvatore Petta, Giovanni Targher et al. Liver International profile →
  30. Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease
    2023 76 citations Giovanni Targher, Alessandro Mantovani et al. ˜The œLancet. Gastroenterology & hepatology profile →
  31. Metabolic Dysfunction–Associated Steatotic Liver Disease
    2025 18 citations Giovanni Targher, Luca Valenti et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Giovanni Targher 28.9k 17.6k 8.8k 8.1k 7.1k 562 44.3k
Giulio Marchesini 24.6k 0.9× 12.4k 0.7× 10.8k 1.2× 3.5k 0.4× 4.3k 0.6× 469 35.6k
Christopher D. Byrne 16.8k 0.6× 10.4k 0.6× 5.2k 0.6× 4.2k 0.5× 3.3k 0.5× 501 26.7k
Naga Chalasani 26.6k 0.9× 10.0k 0.6× 14.2k 1.6× 2.7k 0.3× 4.0k 0.6× 488 36.8k
Elisabetta Bugianesi 27.5k 1.0× 12.8k 0.7× 10.5k 1.2× 3.5k 0.4× 4.2k 0.6× 295 32.9k
Anna Mae Diehl 35.2k 1.2× 14.6k 0.8× 16.2k 1.8× 3.2k 0.4× 6.8k 1.0× 407 51.2k
Arthur J. McCullough 28.0k 1.0× 12.0k 0.7× 12.0k 1.4× 3.0k 0.4× 5.3k 0.7× 292 35.2k
Vincent Wai‐Sun Wong 32.7k 1.1× 8.6k 0.5× 20.7k 2.4× 3.1k 0.4× 3.6k 0.5× 633 44.2k
Elizabeth M. Brunt 38.8k 1.3× 15.6k 0.9× 17.5k 2.0× 3.9k 0.5× 5.2k 0.7× 273 49.9k
Rohit Loomba 39.7k 1.4× 14.2k 0.8× 20.4k 2.3× 3.7k 0.5× 4.7k 0.7× 699 49.8k
Zobair M. Younossi 65.9k 2.3× 24.6k 1.4× 35.2k 4.0× 6.5k 0.8× 9.6k 1.3× 826 75.9k

Countries citing papers authored by Giovanni Targher

Since Specialization
Citations

This map shows the geographic impact of Giovanni Targher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Targher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Targher more than expected).

Fields of papers citing papers by Giovanni Targher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Targher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Targher. The network helps show where Giovanni Targher may publish in the future.

Co-authorship network of co-authors of Giovanni Targher

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Targher. A scholar is included among the top collaborators of Giovanni Targher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Targher. Giovanni Targher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wolfram Saenger Breakdown of academic impact, for papers by Dmitri I. Svergun Breakdown of academic impact, for papers by Markus J. Buehler Breakdown of academic impact, for papers by Jeffrey A. Towbin Breakdown of academic impact, for papers by Leonard B. Saltz Breakdown of academic impact, for papers by Hans Lehrach Breakdown of academic impact, for papers by Clifford J. Rosen Breakdown of academic impact, for papers by Francis J. Keefe
Rankless by CCL
2026